Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1978 Apr 22;118(8):936–940.

Essential hypertension and pregnancy.

R A Bear, N Erenrich
PMCID: PMC1818219  PMID: 348289

Abstract

Approximately 1% of pregnancies are complicated by essential hypertension. During pregnancy the blood pressure often stabilizes or improves. In patients with sustained hypertension, prospective controlled studies have demonstrated enhanced fetal survival when the blood pressure was controlled with antihypertensive medication. Such medication must be chosen carefully to avoid fetal and mateerial toxicity, and diuretics and salt restriction during pregnancy should be avoided. Among patients with essential hypertension the problem accelerates late in pregnancy in 2% to 11%; the acceleration may be predicted by determination of maternal mean arterial pressures and intravascular volumes early in pregnancy. The treatment of accelerated hypertension is identical to that of severe pre-eclampsia. Fetal loss is considerable but can be lessened by careful fetal and maternal monitoring and early controlled delivery. The risks of pregnancy in most patients with essential hypertension are small, and essential hypertension is not a uniform contraindication to pregnancy.

Full text

PDF
936

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALTCHEK A. RENAL BIOPSY AND ITS CLINICAL CORRELATION IN TOXEMIA OF PREGNANCY. Circulation. 1964 Aug;30:SUPPL 2–2:51. doi: 10.1161/01.cir.30.2s2.ii-43. [DOI] [PubMed] [Google Scholar]
  2. Arias F. Expansion of intravascular volume and fetal outcome in patients with chronic hypertension and pregnancy. Am J Obstet Gynecol. 1975 Nov 15;123(6):610–616. doi: 10.1016/0002-9378(75)90883-2. [DOI] [PubMed] [Google Scholar]
  3. BROWNE F. J. Chronic hypertension and pregnancy. Br Med J. 1947 Aug 23;2(4520):283–287. doi: 10.1136/bmj.2.4520.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baskett T. F., Bradford C. R. Active management of severe pre-eclampsia. Can Med Assoc J. 1973 Dec 15;109(12):1209–1211. [PMC free article] [PubMed] [Google Scholar]
  5. Bear R. Pregnancy and lupus nephritis. A detailed report of six cases with a review of the literature. Obstet Gynecol. 1976 Jun;47(6):715–718. [PubMed] [Google Scholar]
  6. Blekta M., Hlavatý V., Trnková M., Bendl J., Bendova L., Chytil M. Volume of whole blood and absolute amount of serum proteins in the early stage of late toxemia of pregnancy. Am J Obstet Gynecol. 1970 Jan 1;106(1):10–13. doi: 10.1016/0002-9378(70)90120-1. [DOI] [PubMed] [Google Scholar]
  7. Cibils L. A. The placenta and newborn infant in hypertensive conditions. Am J Obstet Gynecol. 1974 Jan 15;118(2):256–270. doi: 10.1016/0002-9378(74)90557-2. [DOI] [PubMed] [Google Scholar]
  8. Farahani G., Fenton A. N. Fetal heart rate acceleration in relation to the oxytocin challenge test. Obstet Gynecol. 1977 Feb;49(2):163–166. [PubMed] [Google Scholar]
  9. Foote R. G., Ludbrook A. P. The use of liberal salt diet in pre-eclamptic toxaemia and essential hypertension with pregnancy. N Z Med J. 1973 Apr;77(491):242–245. [PubMed] [Google Scholar]
  10. Fox L. P., Grandi J., Johnson A. H., Watrous W. G., Johnson M. J. Pheochromocytoma associated with pregnancy. Specialty team management and review. Am J Obstet Gynecol. 1969 May 15;104(2):288–295. doi: 10.1016/0002-9378(69)90678-4. [DOI] [PubMed] [Google Scholar]
  11. Freeman R. K. The use of the oxytocin challenge test for antepartum clinical evaluation of uteroplacental respiratory function. Am J Obstet Gynecol. 1975 Feb 15;121(4):481–489. doi: 10.1016/0002-9378(75)90079-4. [DOI] [PubMed] [Google Scholar]
  12. Freund U., French W., Carlson R. W., Weil M. H., Shubin H. Hemodynamic and metabolic studies of a case of toxemia of pregnancy. Am J Obstet Gynecol. 1977 Jan 15;127(2):206–208. doi: 10.1016/s0002-9378(16)33257-4. [DOI] [PubMed] [Google Scholar]
  13. Howie P. W., Prentice C. R., McNicol G. P. Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency. J Obstet Gynaecol Br Commonw. 1971 Nov;78(11):992–1003. doi: 10.1111/j.1471-0528.1971.tb00216.x. [DOI] [PubMed] [Google Scholar]
  14. Johnston C. I., Aickin D. R. The control of high blood pressure during labour with clonidine ("catapres"). Med J Aust. 1971 Jul 17;2(3):132–135. doi: 10.5694/j.1326-5377.1971.tb50463.x. [DOI] [PubMed] [Google Scholar]
  15. Kelly A. M., England P., Lorimer J. D., Ferguson J. C., Govan A. D. An evaluation of human placental lactogen levels in hypertension of pregnancy. Br J Obstet Gynaecol. 1975 Apr;82(4):272–277. doi: 10.1111/j.1471-0528.1975.tb00633.x. [DOI] [PubMed] [Google Scholar]
  16. Kincaid-Smith P., Bullen M., Mills J. Prolonged use of methyldopa in severe hypertension in pregnancy. Br Med J. 1966 Jan 29;1(5482):274–276. doi: 10.1136/bmj.1.5482.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. LANDESMAN R., HOLZE E., SCHERR L. Fetal mortality in essential hypertension. Obstet Gynecol. 1955 Oct;6(4):354–365. [PubMed] [Google Scholar]
  18. MINKOWITZ S., SOLOWAY H. B., HALL J. E., YERMAKOV V. FATAL HEMORRHAGIC PANCREATITIS FOLLOWING CHLOROTHIAZIDE ADMINISTRATION IN PREGNANCY. Obstet Gynecol. 1964 Sep;24:337–342. doi: 10.1097/00006250-196409000-00002. [DOI] [PubMed] [Google Scholar]
  19. Medical staffing in the National Health Service in England and Wales. Lancet. 1968 Aug 24;2(7565):448–448. [PubMed] [Google Scholar]
  20. Michael C. A. The control of hypertension in labour. Aust N Z J Obstet Gynaecol. 1972 Feb;12(1):48–54. doi: 10.1111/j.1479-828x.1972.tb00729.x. [DOI] [PubMed] [Google Scholar]
  21. Nakamura J., Roux J. F., Brown E. G., Sweet A. Y. Total lipids and the lecithin-sphingomyelin ratio of amniotic fluid: an antenatal test of lung immaturity? Am J Obstet Gynecol. 1972 Jun 1;113(3):363–366. doi: 10.1016/0002-9378(72)90685-0. [DOI] [PubMed] [Google Scholar]
  22. Ostergard D. R., Kushinsky S. Urinary estriol as an indicator of fetal well-being. Obstet Gynecol. 1971 Jul;38(1):74–78. [PubMed] [Google Scholar]
  23. Page E. W., Christianson R. The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. Am J Obstet Gynecol. 1976 Jul 15;125(6):740–746. doi: 10.1016/0002-9378(76)90839-5. [DOI] [PubMed] [Google Scholar]
  24. Palomaki J. F., Lindheimer M. D. Sodium depletion simulating deterioration in a toxemic pregnancy. N Engl J Med. 1970 Jan 8;282(2):88–89. doi: 10.1056/NEJM197001082820208. [DOI] [PubMed] [Google Scholar]
  25. Pennington J. C., Picker R. H. Diazoxide and the treatment of the acute hypertensive emergency in obstetrics. Med J Aust. 1972 Nov 4;2(19):1051–1054. [PubMed] [Google Scholar]
  26. Pulkkinen M. O., Willman K. Reduction of maternal estrogen excretion by neomycin. Am J Obstet Gynecol. 1973 Apr 15;115(8):1153–1153. doi: 10.1016/0002-9378(73)90569-3. [DOI] [PubMed] [Google Scholar]
  27. RODRIGUEZ S. U., LEIKIN S. L., HILLER M. C. NEONATAL THROMBOCYTOPENIA ASSOCIATED WITH ANTE-PARTUM ADMINISTRATION OF THIAZIDE DRUGS. N Engl J Med. 1964 Apr 23;270:881–884. doi: 10.1056/NEJM196404232701706. [DOI] [PubMed] [Google Scholar]
  28. Redman C. W. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet. 1976 Oct 9;2(7989):753–756. doi: 10.1016/s0140-6736(76)90597-3. [DOI] [PubMed] [Google Scholar]
  29. Reed R. L., Cheney C. B., Fearon R. E., Hook R., Hehre F. W. Propranolol therapy throughout pregnancy: a case report. Anesth Analg. 1974 Mar-Apr;53(2):214–214. [PubMed] [Google Scholar]
  30. Sarles H. E., Hil S. S., LeBlanc A. L., Smith G. H., Canales C. O., Remmers A. R., Jr Sodium excretion patterns during and following intravenous sodium chloride loads in normal and hypertensive pregnancies. Am J Obstet Gynecol. 1968 Sep 1;102(1):1–7. doi: 10.1016/0002-9378(68)90424-9. [DOI] [PubMed] [Google Scholar]
  31. Schewitz L. J. Hypertension and renal disease in pregnancy. Med Clin North Am. 1971 Jan;55(1):47–69. doi: 10.1016/s0025-7125(16)32543-3. [DOI] [PubMed] [Google Scholar]
  32. Soffronoff E. C., Kaufmann B. M., Connaughton J. F. Intravascular volume determinations and fetal outcome in hypertensive diseases of pregnancy. Am J Obstet Gynecol. 1977 Jan 1;127(1):4–9. doi: 10.1016/0002-9378(77)90305-2. [DOI] [PubMed] [Google Scholar]
  33. Speroff L. Toxemia of pregnancy. Mechanism and therapeutic management. Am J Cardiol. 1973 Sep 20;32(4):582–591. doi: 10.1016/s0002-9149(73)80050-5. [DOI] [PubMed] [Google Scholar]
  34. WELLEN I. The infant mortality in specific hypertensive disease of pregnancy and in essential hypertension. Am J Obstet Gynecol. 1953 Jul;66(1):36–45. doi: 10.1016/0002-9378(53)90283-x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES